|
PSMB5 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.994360E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.470400E-01 |
| Normal-vs-Stage2 |
6.356800E-01 |
| Normal-vs-Stage3 |
3.110000E-01 |
| Normal-vs-Stage4 |
6.290300E-02 |
| Stage1-vs-Stage2 |
5.192400E-02 |
| Stage1-vs-Stage3 |
5.661000E-01 |
| Stage1-vs-Stage4 |
3.052400E-01 |
| Stage2-vs-Stage3 |
1.859200E-01 |
| Stage2-vs-Stage4 |
3.992400E-02 |
| Stage3-vs-Stage4 |
2.082800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.267810E-01 |
| Normal-vs-AfricanAmerican |
5.115500E-02 |
| Normal-vs-Asian |
5.294000E-02 |
| Caucasian-vs-AfricanAmerican |
1.662310E-03 |
| Caucasian-vs-Asian |
3.796600E-01 |
| AfricanAmerican-vs-Asian |
2.394400E-04 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.152400E-02 |
| Normal-vs-Female |
3.837600E-01 |
| Male-vs-Female |
3.890100E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.383900E-02 |
| Normal-vs-Age(41-60Yrs) |
3.831400E-01 |
| Normal-vs-Age(61-80Yrs) |
4.774200E-01 |
| Normal-vs-Age(81-100Yrs) |
4.299000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.025000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.875600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.879400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.438000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.587400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.616000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.780800E-01 |
| Classical-VS-Follicular |
9.379800E-01 |
| Classical-VS-Other |
2.098800E-01 |
| Classical-VS-Normal |
1.711560E-01 |
| Tall-VS-Follicular |
8.924800E-01 |
| Tall-VS-Other |
3.531400E-01 |
| Tall-VS-Normal |
3.940400E-01 |
| Follicular-VS-Other |
3.913600E-01 |
| Follicular-VS-Normal |
3.604800E-01 |
| Other-VS-Normal |
1.083570E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.425200E-01 |
| Normal-vs-N1 |
3.222500E-03 |
| N0-vs-N1 |
7.861900E-03 |
|
|
